Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Tesla
TSLA
|
+$734M |
| 2 |
Apple
AAPL
|
+$407M |
| 3 |
Microsoft
MSFT
|
+$404M |
| 4 |
Amazon
AMZN
|
+$316M |
| 5 |
NVIDIA
NVDA
|
+$307M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$114M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$76.2M |
| 3 |
Exxon Mobil
XOM
|
+$69.4M |
| 4 |
Eli Lilly
LLY
|
+$65.7M |
| 5 |
Cloudflare
NET
|
+$53.2M |
Sector Composition
| 1 | Technology | 31.2% |
| 2 | Financials | 13.98% |
| 3 | Healthcare | 10.92% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Communication Services | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Core Laboratories
CLB
$583M
| $2.11M | ﹤0.01% |
140,487
-4,792
| -3% | -$71.8K |
|
1902
Dorian LPG
LPG
$1.39B
| $2.1M | ﹤0.01% |
93,778
-3,222
| -3% | -$72K |
|
1903
Amicus Therapeutics
FOLD
$2.38B
| $2.09M | ﹤0.01% |
256,533
-531
| -0.2% | -$4.33K |
|
1904
VSE Corp
VSEC
$3.42B
| $2.09M | ﹤0.01% |
17,426
+1,471
| +9% | +$177K |
|
1905
Argan
AGX
$3.3B
| $2.09M | ﹤0.01% |
15,939
+231
| +1% | +$30.3K |
|
1906
Myriad Genetics
MYGN
$680M
| $2.09M | ﹤0.01% |
235,375
-10,771
| -4% | -$95.5K |
|
1907
Par Pacific Holdings
PARR
$1.7B
| $2.08M | ﹤0.01% |
145,523
-4,799
| -3% | -$68.4K |
|
1908
Denali Therapeutics
DNLI
$1.92B
| $2.07M | ﹤0.01% |
151,962
+2,449
| +2% | +$33.3K |
|
1909
RingCentral
RNG
$2.79B
| $2.06M | ﹤0.01% |
83,392
+2,785
| +3% | +$69K |
|
1910
Atour Lifestyle Holdings
ATAT
$5.49B
| $2.05M | ﹤0.01% |
72,414
+314
| +0.4% | +$8.9K |
|
1911
Akero Therapeutics
AKRO
$3.43B
| $2.04M | ﹤0.01% |
50,499
+419
| +0.8% | +$17K |
|
1912
OneSpaWorld
OSW
$2.25B
| $2.04M | ﹤0.01% |
121,472
-3,800
| -3% | -$63.8K |
|
1913
SunCoke Energy
SXC
$669M
| $2.04M | ﹤0.01% |
221,555
-6,916
| -3% | -$63.6K |
|
1914
Astec Industries
ASTE
$1.09B
| $2.04M | ﹤0.01% |
59,143
-1,839
| -3% | -$63.4K |
|
1915
Takeda Pharmaceutical
TAK
$47.6B
| $2.03M | ﹤0.01% |
136,715
| – | – |
|
1916
PC Connection
CNXN
$1.61B
| $2.03M | ﹤0.01% |
32,559
-2,013
| -6% | -$126K |
|
1917
Ichor Holdings
ICHR
$586M
| $2.03M | ﹤0.01% |
89,746
-4,921
| -5% | -$111K |
|
1918
Xenon Pharmaceuticals
XENE
$2.78B
| $2.03M | ﹤0.01% |
60,406
| – | – |
|
1919
XPeng
XPEV
$20.3B
| $2.03M | ﹤0.01% |
97,726
-1,222
| -1% | -$25.3K |
|
1920
Tompkins Financial
TMP
$992M
| $2.03M | ﹤0.01% |
32,174
-1,022
| -3% | -$64.4K |
|
1921
Liberty Global Class A
LBTYA
$4.05B
| $2.03M | ﹤0.01% |
176,015
+16,599
| +10% | +$191K |
|
1922
Marqeta
MQ
$2.6B
| $2.02M | ﹤0.01% |
489,079
+18,332
| +4% | +$75.5K |
|
1923
SpartanNash
SPTN
$890M
| $2.01M | ﹤0.01% |
99,388
-2,902
| -3% | -$58.8K |
|
1924
Scansource
SCSC
$985M
| $2.01M | ﹤0.01% |
58,988
-3,482
| -6% | -$118K |
|
|
PRSU
1925
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.03B
| $2M | ﹤0.01% |
56,407
-514
| -0.9% | -$18.2K |
|